Sodium channel blockers and axonal protection in neuroinflammatory disease

Brain

Volumn 128, Issue 1, 2005, Pages 5-6

  Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Rehabilitation Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE; NITRIC OXIDE; PHENYTOIN; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

ALLERGIC ENCEPHALOMYELITIS; DEMYELINATION; ENCEPHALITIS; GENE EXPRESSION REGULATION; GRAY MATTER; GUILLAIN BARRE SYNDROME; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE PROJECTION; NEUROPROTECTION; NONHUMAN; NOTE; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SCHWANN CELL; SODIUM CALCIUM EXCHANGE; WHITE MATTER;

AXONS; DEMYELINATING DISEASES; ENCEPHALOMYELITIS; GUILLAIN-BARRE SYNDROME; HUMANS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; OXYGEN; SODIUM CHANNEL BLOCKERS;

EID: 11244300731     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh353     Document Type: Note

References (20)

1. Bechtold DA, Kapoor R, Smith KJ. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 2004; 55: 607-16.
2. Bechtold DA, Yue X, Evans RM, Davies M, Gregson NA, Smith KJ. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain. In press 2005.
3. Craner MJ, Hains BC, Lo AC, Black JA, Waxman SG. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 2004a; 127: 294-303.
4. 2+ 2, exchanger. Proc Natl Acad Sci USA 2004b; 101: 8168-73.
5. Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, Black JA, et al. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia. In press 2004c.
6. Cummins TR, Dib-Hajj SD, Black JA, Akopian AN, Wood JN, Waxman SG. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci 1999; 19: 1-6.
7. Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel preferentially expressed in peripheral sensory neurons and down-regulated following axotomy. Proc Natl Acad Sci USA 1998; 95: 8963-8.
8. v1.9 (NaN) in nociceptive primary afferent neurons. J Neurosci 2002; 22: 7425-33.
9. v1.7 sodium channels in spinal sensory neurons. J Physiol 2003; 551: 741-51.
10. Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ. Blockers of sodium and calcium entry protect axons form nitric oxide-mediated degeneration. Ann Neurol 2003; 53: 74-80.
11. Lo AC, Black JA, Waxman SG. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport 2002; 13: 1909-12.
12. Lo AC, Saab CY, Black JA, Waxman SG. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 2003; 90: 3566-72.
13. v1.9 in mouse DRG neurons via G-proteins. Brain Res. In press 2004.
14. Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002; 1: 232-41.
15. Smith KJ, Kapoor R, Hall SM, Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001; 49: 470-6.
16. Sontheimer H, Black JA, Waxman SG. Voltage-gated sodium channels in glia: properties and possible functions. Trends Neurosci 1996; 19: 325-32.
17. 2+ exchanger. J Neurosci 1992a; 12: 430-9.
18. Stys PK, Ransom BR, Waxman SG. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 1992b; 67: 236-40.
19. Stys PK, Sontheimer H, Ransom BR, Waxman SG. Non-inactivating, TTX-sensitive Na+ conductance in rat optic nerve axons. Proc Natl Acad Sci USA 1993; 90: 6976-80.
20. + conductance in peripheral axons. Muscle Nerve 2003; 28: 212-7.